This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone September 2026 quarter: revenue up 16%, profit after tax down; directors changed
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.6 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone quarter ended 30 September 2026 versus 30 September 2025 showed revenue of Rs 1,692.01 lakh versus Rs 1,457.77 lakh, up 16.1%, and profit after tax of Rs 97.61 lakh versus Rs 203.96 lakh. EBITDA margin fell to 6.9% from 19.4%. The standalone half year to 30 September 2026 had negative operating cash flow of Rs 43.20 lakh. Borrowings were 2.01 times equity. Arvind Goenka joined as an additional director; Aanchal Goenka resigned.
Revenue grew, but profit and margin fell. Negative operating cash flow and borrowings at 2.01 times equity add risk for shareholders and the stock.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹21.04 Cr | ₹9.46 Cr | +122.5% |
| Operating profit | ₹1.43 Cr | −₹0.25 Cr | turned positive |
| Profit after tax | ₹0.98 Cr | −₹0.24 Cr | turned positive |
| EBITDA margin | 9.3% | 2.8% | +6.4 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.